Alcidion Group (ASX:ALC) awarded $23.5m contract with Commonwealth

Company News

by Adrian Tan

Alcidion Group Limited (ASX:ALC), as part of a consortium of digital health partners, has been awarded a contract to deliver components of a health project for the Commonwealth of Australia.

The value of the contract to Alcidion is an estimated $23.5 million over six years, with the possibility of renewal. Project commencement is planned for December 2021.

The consortium is led by Leidos Australia, part of a global IT and engineering consulting firm. Alcidion will provide the Longitudinal Health Record via its Miya Precision product. Miya Precision is a FHIR (Fast Healthcare Interoperability Resources) platform that consolidates information from disparate systems, applying artificial intelligence to yield actionable insights.

Shares in Alcidion Group (ASX:ALC) are trading 7.9 per cent higher at $0.34. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.